U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT06306001) titled 'Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock' on Feb. 20.
Brief Summary: Preterm infants (born at less than 37 weeks of pregnancy) sometimes develop a serious blood infection leading to low blood pressure, which does not respond to saline or to the standard medicines for increasing blood pressure, such as dopamine and epinephrine. The goal of this research study is to compare the effect of giving an injectable medicine called Methylene blue (MB) versus not giving MB to such preterm infants who are unresponsive to standard treatment. The main questions that this study aims to answer is:
* Whether MB trea...